Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PYC THERAPEUTICS LIMITED Capital/Financing Update 2015

Jul 19, 2015

65640_rns_2015-07-19_f6b129be-7cc1-43c1-8cdc-79580168a031.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [39 x 34] intentionally omitted <==

20[th] July 2015

Market Announcements Platform Australian Securities Exchange

Non-Renounceable Entitlement Issue – Extension of Closing Date

Phylogica Limited refers to the Entitlement Issue which opened on 14[th] July 2015 and advises that the Closing Date of the Issue has been extended until Friday 31[st] July 2015.

The revised timetable estimated for the remainder of the Issue is set out below.

Event Date
Closing Dates for acceptances 31 July 2015
New Shares quoted on deferred settlement basis 4 August 2015
ASX notified of undersubscriptions 5 August 2015
Allotment and issue of New Shares 7 August 2015
Despatch of shareholding statements for New Shares 7 August 2015
Trading of New Shares expected to commence 10 August 2015

Note : These dates are determined based upon the current expectations of the Directors and, subject to the Listing Rules, may be changed without notice. The Directors may extend the Closing Date by giving at least 3 Business Days notice to ASX prior to the Closing Date. As such, the date the Shares are expected to commence trading on ASX may vary.

For and on behalf of Phylogica Limited

==> picture [139 x 69] intentionally omitted <==

Graeme Boden

Company Secretary

Phylogica Limited ABN 48 098 391 961 PO Box 8207, Subiaco East, Western Australia 6008 Tel: +61 8 9384 3284 Fax: +61 8 9284 3801 www.phylogica.com